MedPath

Is internet-delivered therapy more effective than internet-delivered brief support in reducing depressive symptoms in adolescents?

Not Applicable
Completed
Conditions
Mild to moderate depression in adolescents
Mental and Behavioural Disorders
Registration Number
ISRCTN16206254
Lead Sponsor
Department of Psychology, Stockholm University
Brief Summary

2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32224489 results (added 01/04/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32765315/ results (added 10/08/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36473231/ findings from interviews (added 08/12/2022) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32799772/ Sudden gains and large intersession improvements (added 28/02/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
76
Inclusion Criteria

1. Adolescents 15-18 years of age
2. Suffering from mild to moderate symptoms of depression according to a diagnostic interview (MINI 7.0).
3. Have access to a computer/smartphone/tablet with internet connection
4. Able to read, write and speak Swedish without the aid of an interpreter.

Exclusion Criteria

1. Risk of suicidality and/or earlier suicide attempts,
2. Partaking in other psychological treatment,
3. Psychotropic medication not stable since at least three months,
4. Other primary diagnoses in need of other treatment
5. Current fulfillment of any of the following diagnoses: any psychotic disorder, bipolar I/II disorder, antisocial personality disorder, and autism-spectrum disorder.
6. Comorbid drug or alcohol abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Depressive symptoms will be measured using the Quick Inventory of Depressive Symptomatology in Adolescents (Bernstein et al., 2010) via internet delivered self-rating forms pre-treatment, weekly during treatment and post-treatment.<br>1.1. In order to fully explore trajectories of change and possible moderating and mediating factors over time, a parallel process latent growth curve strategy will be employed.<br>2. Differences in efficacy between conditions will be investigated by modelling interaction effects of group and time.
Secondary Outcome Measures
NameTimeMethod
1. Anxiety symptoms will be measured weekly using the Generalised Anxiety Disorder 7- item scale (GAD-7; Kroenke et al., 2010).<br>2. The severity of depression symptoms will be measured pre- and post-treatment using the Montgomery Åsberg Depression Rating Scale (Svanborg & Åsberg, 1994).
© Copyright 2025. All Rights Reserved by MedPath